Cargando…
Effect of Glycosaminoglycan Replacement on Markers of Interstitial Cystitis In Vitro
Aims: To examine the effect of three commercial intravesical formulations of glycosaminoglycan on in vitro inflammatory models of IC/BPS to better understand there effect on specific markers of disease. Methods: Human urothelial cells (HTB-4) were cultured under four conditions in the presence or ab...
Autores principales: | Rooney, Peadar, Ryan, Christina, McDermott, Barry J., Dev, Kapil, Pandit, Abhay, Quinlan, Leo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775665/ https://www.ncbi.nlm.nih.gov/pubmed/33390947 http://dx.doi.org/10.3389/fphar.2020.575043 |
Ejemplares similares
-
A high molecular weight hyaluronic acid biphasic dispersion as potential therapeutics for interstitial cystitis
por: Rooney, Peadar R., et al.
Publicado: (2020) -
Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy
por: Cervigni, Mauro
Publicado: (2015) -
Defining Molecular Treatment Targets for Bladder Pain Syndrome/Interstitial Cystitis: Uncovering Adhesion Molecules
por: Inal-Gultekin, Guldal, et al.
Publicado: (2022) -
Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis/Bladder Pain Syndrome in Rats
por: Augé, Céline, et al.
Publicado: (2020) -
Intravesical Glycosaminoglycan Replacement with Chondroitin Sulphate (Gepan(®) instill) in Patients with Chronic Radiotherapy- or Chemotherapy-Associated Cystitis
por: Schwalenberg, Thilo, et al.
Publicado: (2015)